Promising Agent Significantly Improves Disability in GBS ...Middle East

Medscape - News
An investigational targeted immunotherapy for Guillain-Barré syndrome more than doubled improvement in disability after 8 weeks and showed sustained benefit at 26 weeks. Medscape Medical News

Hence then, the article about promising agent significantly improves disability in gbs was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Promising Agent Significantly Improves Disability in GBS )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News